Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harvey G Moore

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cancer|December 17, 2016
Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United StatesYvonne M Mowery, Joseph K Salama, S Yousuf Zafar, et al.
Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.
Diseases of the Colon and Rectum|November 13, 2004
Colorectal cancer pelvic recurrences: determinants of resectabilityHarvey G Moore, Margo Shoup, Elyn Riedel, et al.
Journal of the American College of Surgeons|June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancerJose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Diseases of the Colon and Rectum|March 3, 2004
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore, Alicia E Gittleman, Bruce D Minsky, et al.
Journal of Gastrointestinal Oncology|October 22, 2015
Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology centerDanielle S Bitterman, David Grew, Ping Gu, et al.
International Journal of Colorectal Disease|June 5, 2003
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapyAntonio I Picon, Harvey G Moore, Stephen S Sternberg, et al.
The American Journal of Surgical Pathology|March 27, 2004
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcomeJinru Shia, Jose G Guillem, Harvey G Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end pointJose G Guillem, David B Chessin, Jinru Shia, et al.
Annals of Surgery|March 8, 2022
A Multidimensional Bioinformatic Platform for the Study of Human Response to SurgeryAustin M Eckhoff, Ashton A Connor, Julie K M Thacker, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cancer|December 17, 2016
Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United StatesYvonne M Mowery, Joseph K Salama, S Yousuf Zafar, et al.
Annals of Surgical Oncology|November 5, 2004
Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcomeHarvey G Moore, Jinru Shia, David S Klimstra, et al.
Diseases of the Colon and Rectum|November 13, 2004
Colorectal cancer pelvic recurrences: determinants of resectabilityHarvey G Moore, Margo Shoup, Elyn Riedel, et al.
Journal of the American College of Surgeons|June 26, 2004
Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancerJose G Guillem, Harvey G Moore, Timothy Akhurst, et al.
Diseases of the Colon and Rectum|March 3, 2004
Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resectionHarvey G Moore, Alicia E Gittleman, Bruce D Minsky, et al.
Journal of Gastrointestinal Oncology|October 22, 2015
Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology centerDanielle S Bitterman, David Grew, Ping Gu, et al.
International Journal of Colorectal Disease|June 5, 2003
Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapyAntonio I Picon, Harvey G Moore, Stephen S Sternberg, et al.
The American Journal of Surgical Pathology|March 27, 2004
Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcomeJinru Shia, Jose G Guillem, Harvey G Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 24, 2005
Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end pointJose G Guillem, David B Chessin, Jinru Shia, et al.
Annals of Surgery|March 8, 2022
A Multidimensional Bioinformatic Platform for the Study of Human Response to SurgeryAustin M Eckhoff, Ashton A Connor, Julie K M Thacker, et al.
Pageof 3